UniProtKB/Swiss-Prot O60934: Variant p.Lys408Glu

Nibrin
Gene: NBN
Feedback?

Variant information Variant position:

408 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Lysine (K) to Glutamate (E) at position 408 (K408E, p.Lys408Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (K) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs34120922 [ dbSNP | Ensembl ]

Sequence information Variant position:

408 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

754 The length of the canonical sequence.
Location on the sequence:

KMEQKFRMLSQDAPTVKESC K TSSNNNSMVSNTLAKMRIPN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KMEQKFRMLSQDA---PTVKESCKTSSNNNSMV----SNTLAKMRIPN

Mouse                         GLEQSSRKLSQET---FNIKEAPKPSSKANNVA----SDTL

Rat                           GLDQNSRKLLQGT---CNIKETSNQSSNSNNAA----SNTL

Chicken                       SQTTRREKVAFQQ---AAVRENPSTSGTVNAGMLISRVNRT

Xenopus laevis                PGNSSSHSRSKG-----CLQKDPKSGSSSNDLR----QTLF

Zebrafish                     PEKTNPTQKASTTNKPLSLGQEPSSTRIVQETVMSSESFSV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 754	Nibrin
Region	396 – 415	Disordered
Modified residue	388 – 388	N6-lactoyllysine
Modified residue	397 – 397	Phosphoserine
Modified residue	402 – 402	Phosphothreonine
Mutagenesis	388 – 388	K -> R. Abolished lactylation, leading to decreased recruitment of the MRN complex to DNA damage sites.
Mutagenesis	397 – 397	S -> A. Abrogates ATM-dependent phosphorylation. No loss of interaction with KPNA2.

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.